Literature DB >> 12403553

NF1 mutations and molecular testing.

Susanne A M Thomson1, Lauren Fishbein, Margaret R Wallace.   

Abstract

Neurofibromatosis 1 is a progressive autosomal dominant condition caused by mutations in the NF1 gene on chromosome 17. The condition shows clinical variable expressivity, with varying features even between family members who share the same mutation. Furthermore, it is impossible to precisely predict the severity and course of the condition, a source of frustration for families and physicians. Neurofibromatosis 1 is also heterogeneous at the mutation level, with more than 300 independent mutations having been reported in this gene. The mutation data have accumulated slowly owing to the variability of the mutation types and the size and complexity of the gene. This is also reflected in the lack of a simple, inexpensive, highly accurate DNA-based test for neurofibromatosis 1 at present. This article reviews current NF1 mutation spectrum and testing, discussing and illustrating mutation mechanisms and pathogenetic effects, as well as factors affecting DNA testing and interpretation/diagnosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403553     DOI: 10.1177/088307380201700803

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  8 in total

Review 1.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

2.  Functional analysis of splicing mutations in exon 7 of NF1 gene.

Authors:  Irene Bottillo; Alessandro De Luca; Annalisa Schirinzi; Valentina Guida; Isabella Torrente; Stefano Calvieri; Cristina Gervasini; Lidia Larizza; Antonio Pizzuti; Bruno Dallapiccola
Journal:  BMC Med Genet       Date:  2007-02-12       Impact factor: 2.103

3.  The Number of Surgical Interventions and Specialists Involved in the Management of Patients with Neurofibromatosis Type I: A 25-Year Analysis.

Authors:  Chih-Kai Hsu; Rafael Denadai; Chun-Shin Chang; Chuan-Fong Yao; Ying-An Chen; Pang-Yun Chou; Lun-Jou Lo; Yu-Ray Chen
Journal:  J Pers Med       Date:  2022-04-01

4.  Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis.

Authors:  German Melean; Alba Marina Hernández; María Carmen Valero; Elisabete Hernández-Imaz; Yolanda Martín; Concepción Hernández-Chico
Journal:  BMC Cancer       Date:  2010-08-05       Impact factor: 4.430

5.  Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.

Authors:  Victor-F Mautner; Florence A Asuagbor; Eva Dombi; Carsten Fünsterer; Lan Kluwe; Ralf Wenzel; Brigitte C Widemann; Jan M Friedman
Journal:  Neuro Oncol       Date:  2008-06-17       Impact factor: 12.300

6.  Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor.

Authors:  Hiroshi Nemoto; Genshu Tate; Annalisa Schirinzi; Takao Suzuki; Shoji Sasaya; Yasuo Yoshizawa; Takemasa Midorikawa; Toshiyuki Mitsuya; Bruno Dallapiccola; Yutaka Sanada
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

7.  Screening for mutation site on the type I neurofibromatosis gene in a family.

Authors:  Ming Lv; Wenhua Zhao; Lin Yan; Liang Chen; Kai Cui; Jie Gao; Fachang Yu; Sheng Li
Journal:  Childs Nerv Syst       Date:  2011-12-30       Impact factor: 1.475

8.  Comparison of hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1.

Authors:  Roy A Raad; Shailee Lala; Jeffrey C Allen; James Babb; Carole Wind Mitchell; Ana M Franceschi; Kaleb Yohay; Kent P Friedman
Journal:  World J Nucl Med       Date:  2018 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.